The global epoprostenol sodium drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Epoprostenol sodium drug is used in human vascular tissue. It is acidic in nature with a molecular weight of 374.45, and the drug treats pulmonary hypertension. Epoprostenol sodium drug is also used in clinical research and diagnosis. It belongs to the well-known class of drugs called vasodilators, which helps in improving tiredness, shortness of breath, and infection. Moreover, this drug is used in the healthcare sector for blood thinning and thus prevents blood clotting. 

The drug’s haemodynamic effects are also used to delay the need for transplant surgery. Therefore, its demand has been consistently rising in the healthcare sector, thereby facilitating the growth of the market. Apart from this, cost-effectiveness is another factor that is driving the growth of the global epoprostenol market during the forecast period. Furthermore, the global epoprostenol sodium drugs market analysis includes some of the key market players such as Sun Pharmaceutical Industries Ltd., Pfizer CentreOne, Inc., Sanofi SA, Ausun Pharmaceutical Co. Ltd., and Actelion Pharms Ltd., among others. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Sun Pharmaceutical Industries Ltd., Pfizer CentreOne, Inc., Sanofi SA, Ausun Pharmaceutical Co. Ltd., and Actelion Pharms Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Epoprostenol Sodium Drugs Market by Segment

By Type 

• 0.5 mg

• 1.5 mg

By Application 

• Hospital

• Clinic

Global Epoprostenol Sodium Drugs Market by Regional Analysis